EUVIMEDEUVIMED entdecken
Crossref

Fuzheng Kang’ai decoction suppresses hepatocellular carcinoma via regulation of the KLF4/HIF-1α/CA9 signaling axis

Yi Cui, Yuhan Zhang, Jinwei Zhang, Zhenghong Chen, Bin Yuan, Wenjuan Chen, Le Han, Bin Zhao, Yili Zhang, Peixi Zhao

Archives of Medical Science · 01.04.2026

DOI: 10.5114/aoms/216399 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archives of Medical Science, online erschienen am 01.04.2026. Verfasst von Yi Cui und 9 weiteren Autor:innen. Die Arbeit nennt 53 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Clinical studies have established the efficacy of Fuzheng Kang’ai formula (FZKAF) in hepatocellular carcinoma (HCC) management. The molecular basis of FZKAF’s HCC-suppressive effects is not fully characterized. This investigation aimed to mechanistically delineate FZKAF’s therapeutic actions against HCC. Material and methods Phytochemical characterization via liquid chromatography-mass spectrometry (LC-MS) established the decoction’s bioactive constituents. CCK-8 assays quantified proliferative suppression and cytotoxicity, while Annexin V-FITC/PI staining and cell cycle analysis mapped apoptosis induction. Integrated proteomic and transcriptomic profiling screened core targets and signaling pathways. Therapeutic efficacy was ultimately confirmed in an orthotopic HCC nude mouse model.

Results

Phytochemical profiling identified 33 bioactive compounds in serum following FZKAF administration, including 9 established anti-tumor agents such as paeoniflorin, catechin, kaempferol, and quercetin. Functionally, FZKAF demonstrated dual anti-HCC efficacy by suppressing tumor growth in vivo and inhibiting 97H cell proliferation in vitro while promoting apoptosis through mitochondrial dysfunction. Mechanistic interrogation via multi-omics revealed FZKAF coordinately modulates KLF4, HIF-1a, and CA9 targets to disrupt oncogenic signaling.

Conclusions

FZKAF orchestrates apoptosis induction and growth suppression in HCC, at least partially, by modulating the KLF4/HIF-1a/CA9 signaling axis, revealing a novel druggable pathway that advances precision oncology strategies for HCC patients.

Zitieren

APA

Cui, Y., Zhang, Y., Zhang, J., Chen, Z., Yuan, B., Chen, W., Han, L., Zhao, B., Zhang, Y., & Zhao, P. (2026). Fuzheng Kang’ai decoction suppresses hepatocellular carcinoma via regulation of the KLF4/HIF-1α/CA9 signaling axis. Archives of Medical Science. https://doi.org/10.5114/aoms/216399

Vancouver

Cui Y, Zhang Y, Zhang J, Chen Z, Yuan B, Chen W, et al. Fuzheng Kang’ai decoction suppresses hepatocellular carcinoma via regulation of the KLF4/HIF-1α/CA9 signaling axis. Archives of Medical Science. 2026. doi:10.5114/aoms/216399

BibTeX
@article{Cui2026,
  author = {Cui, Yi and Zhang, Yuhan and Zhang, Jinwei and Chen, Zhenghong and Yuan, Bin and Chen, Wenjuan and Han, Le and Zhao, Bin and Zhang, Yili and Zhao, Peixi},
  title = {Fuzheng Kang’ai decoction suppresses hepatocellular carcinoma via regulation of the KLF4/HIF-1α/CA9 signaling axis},
  journal = {Archives of Medical Science},
  year = {2026},
  doi = {10.5114/aoms/216399}
}
Kostenlos starten →